Institute of Science Tokyo · Faculty of Medicine

Research keywordsinflammatory bowel disease・ulcerative colitis・Crohn disease・tofacitinib・mucosal healing・intestinal imaging

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Matsuoka K, Yamazaki H, Nagahori M, Kobayashi T, Omori T, Mikami Y, Fujii T, Shinzaki S, Saruta M, Matsuura M, Yamamoto T, Motoya S, Hibi T, Watanabe M, Fernandez J, Fukuhara S, Hisamatsu T. Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study. Journal of gastroenterology. 2024.07; 59 (7): 644-646. ( PubMed , DOI )2024
• Shimizu H, Aonuma Y, Hibiya S, Kawamoto A, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Okamoto R. Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study. Intestinal research. 2024.07; ( PubMed , DOI )2024
• 長堀 正和. 【感染症を鑑別したあとは?非感染性腸炎を見極める!】代表的な非感染性腸炎の診療と紹介時の見極めかた 器質的異常に伴う大腸炎 憩室炎,虚血性腸炎ほか 診断と治療. 2024.03; 112 (3): 365-368. ( 医中誌 )2024
• Fujiwara S, Kawamoto A, Motobayashi M, Hibiya S, Takenaka K, Shimizu H, Saito E, Fujii T, Nagahori M, Kawata D, Umezawa N, Hosoya T, Yasuda S, Ohtsuka K, Okamoto R. Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab. DEN open. 2023.04; 3 (1): e196. ( PubMed , DOI )2023

• Official profile
• ORCID